한국   대만   중국   일본 
Indegene - Wikipedia Jump to content

Indegene

Add links
From Wikipedia, the free encyclopedia

Indegene Limited
Formerly Indegene Lifesystems Private Limited (1998?2016)
Indegene Private Limited (2016?2022)
Company type Public
Industry
Founded 1998 ; 26 years ago  ( 1998 )
Founders Rajesh Nair
Manish Gupta
Sanjay Parikh
Anand Kiran
Gaurav Kapoor
Headquarters
Bangalore
,
India
Area served
Worldwide
Key people
Manish Gupta (CEO) [1]
Revenue Increase ? 2,589 crore (US$310 million) (FY24) [2]
Increase ? 584 crore (US$70 million) (FY24) [2]
Increase ? 336 crore (US$40 million) (FY24) [2]
Owners
Number of employees
5,081 (March 2024) [2]
Website www .indegene .com

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. [4] [5] [6] Based in Bangalore , the company specializes in pharmaceutical marketing , clinical trials , pharmacovigilance , medical and regulatory affairs , and health informatics . [7] [8]

History [ edit ]

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran. [9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States. [10] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States. [6] [11]

In 2009, Indegene signed a master service agreement with six pharmaceutical companies. [5] [12] The following year, Indegene acquired Canada -based Aptilon, a multichannel marketing firm, for $4 million. [13] The company subsequently acquired Atlanta -based Total Therapeutic Management in 2014. [14]

In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million. [15]

In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene. [16] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million. [17]

Indegene went public in May 2024 with an initial public offering , raising ? 1,842 crore (US$220 million). It listed on the BSE and the NSE . [18] [19]

Operations [ edit ]

Indegene has offices in India, the United States, the European Union , and Asia-Pacific . [20] [11]

In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry. [21]

See also [ edit ]

References [ edit ]

  1. ^ "Indegene on the prowl for global acquisitions" . The Hindu Businessline . 12 August 2020 . Retrieved 8 January 2023 .
  2. ^ a b c d "Fact Sheet ? Q4 FY2024" (PDF) . Indegene . Retrieved 30 May 2024 .
  3. ^ "PE firms Carlyle, Nadathur Fareast, Brighton Park Capital-backed Indegene IPO to open on May 6" . Moneycontrol . Retrieved 28 April 2024 .
  4. ^ Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff" . The Economic Times . Retrieved 2 October 2015 .
  5. ^ a b Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing" . Mint . Retrieved 2 October 2015 .
  6. ^ a b Unnikrishnan, CH (8 November 2006). "Indegene buys US firm" . Business Standard . Retrieved 2 October 2015 .
  7. ^ Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention" . The Nikkei . Retrieved 2 October 2015 .
  8. ^ "Indegene files papers with Sebi; eyes ?3,200 crore via IPO" . mint . 15 December 2022 . Retrieved 8 January 2023 .
  9. ^ Amirapu, Deepika (9 March 2012). "Indegene eyes US call centre buy for $10?15 million" . The Economic Times . Retrieved 2 October 2015 .
  10. ^ D'Silva, Jeetha (17 September 2005). "Indegene acquires US medical education co" . The Economic Times . Retrieved 2 October 2015 .
  11. ^ a b "Indegene acquires MedCases, LLC" . NFV Zone. 30 November 2006 . Retrieved 2 October 2015 .
  12. ^ "Indegene highlights benefits of patient adherence programs for pharma cos" . PharmaBiz. 3 June 2011 . Retrieved 2 October 2015 .
  13. ^ Mukherjee, Rupali (7 November 2012). "Indegene to acquire Canada-based company for $4 million" . Times of India . Retrieved 2 October 2015 .
  14. ^ Craig, Tara (9 January 2014). "Indegene acquires Total Therapeutic Management" . PMLive.com . Retrieved 2 October 2015 .
  15. ^ Balakrishnan, Reghu (3 September 2019). "Healthcare tech firm Indegene acquires DT Associates" . The Economic Times . Retrieved 28 April 2024 .
  16. ^ Madhurima, Nandy (3 February 2021). "Indegene to raise $200 mn from Carlyle, Brighton Park" . LiveMint . Retrieved 20 August 2021 .
  17. ^ Baruah, Ayushman (30 August 2021). "Indegene acquires US-based Medical Marketing Economics for $10 mn" . Mint . Retrieved 28 April 2024 .
  18. ^ Narayanan, KS Badri (6 May 2024). "Indegene IPO opens today in ?430-452 price band" . BusinessLine . Retrieved 6 May 2024 .
  19. ^ "Indegene IPO - UpcomingIPOTracker" . UpcomingIPOTracker . 10 May 2024.
  20. ^ Vijay, Nandita (7 November 2012). "Indegene plans next phase of growth through acquisition in US, EU markets" . PharmaBiz . Retrieved 2 October 2015 .
  21. ^ "Best companies to work for 2012: Companies that came up trumps across various sectors" . The Economic Times . 16 July 2012 . Retrieved 2 October 2015 .
Retrieved from " https://en.wikipedia.org/w/index.php?title=Indegene&oldid=1228469637 "